Please login to the form below

Cello Health appoints health economics and market access expert in the United States

Yardley, PA June 6, 2016 - Today, Cello Health, a global provider of marketing advisory services to the pharmaceutical and health sectors, announced the appointment of Yi Han, PhD, MBA, as Executive Vice President of Market Access and HEOR in the US.  

Han has 15 years of experience in leadership positions in both biotechnology and pharmaceutical companies, such as IPSEN Biopharmaceuticals, Hoffmann-La Roche, and GlaxoSmithKline, and also in service firms.  Prior to joining Cello Health, Han was a Senior Vice President at Grey Health Group and led the market access consultancy WG Consulting.   
Han specializes in health economics, market access strategy, and data mining.  He also has extensive experience in launching and life cycle management of pharmaceutical products, vaccines, and medical devices in US and global markets.  He has made significant contributions to help clients establish pricing and contracting strategy at the product or portfolio level to secure optimal revenue growth.  

Julia Ralston, CEO of Cello Health, US, commented, “Yi brings us the perfect blend of technical and commercial expertise in HEOR data generation and also market access strategy and consulting.  He will lead the growth of our market access and HEOR services, leveraging the pre-existing HEOR and market access skills across our communications, consulting, and market research capabilities to drive our rapid expansion in this area that is so essential to our clients’ commercial success.”  

Han will be based at Cello Health’s Yardley, PA office, where the existing Cello Health Communications business unit has a legacy service offering in the dissemination of HEOR data.  Cello Health has offices in Boston, New York City, Philadelphia, Chicago, San Francisco, and London.

About Cello Health: Cello Health delivers cutting-edge professional marketing services to the global pharmaceutical and health sectors. Cello Health consists of three distinct capabilities to deliver a fusion of expertise to unlock the potential of organizations, brands and assets:
  • Cello Health Insight: global marketing research and customer insight
  • Cello Health Consulting: strategic consultancy
  • Cello Health Communications: evidence and engagement

6th June 2016


Company Details

Cello Health

+44 (0)20 7812 8460

Contact Website

31 Old Nichol St, Shoreditch
E2 7HR

Latest content on this profile

Cello Health Recognised As One Of The Sunday Times Best Companies To Work For 2020
We're delighted to announce that Cello Health has been recognised as number 71 on the annual Sunday Times Best Companies to Work For list
Cello Health
Breaking Blue Research Joins Cello Health Insight
We’re delighted to announce that our sister agency Breaking Blue Research is formally joining Cello Health Insight
Cello Health
Cello Health Acquire ISS
Acquisition further strengthens technical advisory services in US
Cello Health
Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.
London, July 08, 2019 Cello Health GmbH opens in Berlin with its Business Insights and Analytics division, Cello Health Insight, appointing two regional directors: Heike Tombrink – Regional Director, Head of Cello Health Insight Germany, and Matthias Heurich – Regional Director, supporting Digital Innovation.
Cello Health
Cello Health Insight wins EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'
Cello Health Insight in partnership with Janssen Pharmaceuticals has won EphMRA’s 2019 Market Research Excellence Award for 'Business Impact through Innovation'.
Cello Health
Cello Health Launches New Social Insight & Analytics Business
Cello Health Logic offers pharmaceutical companies the ability to make sense of healthcare social media conversations and deliver actionable insights.
Cello Health